Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

1.

Surface-modified nanoparticles enhance transurothelial penetration and delivery of survivin siRNA in treating bladder cancer.

Martin DT, Steinbach JM, Liu J, Shimizu S, Kaimakliotis HZ, Wheeler MA, Hittelman AB, Mark Saltzman W, Weiss RM.

Mol Cancer Ther. 2014 Jan;13(1):71-81. doi: 10.1158/1535-7163.MCT-13-0502. Epub 2013 Nov 12.

PMID:
24222663
[PubMed - in process]
2.

Nanoparticles for urothelium penetration and delivery of the histone deacetylase inhibitor belinostat for treatment of bladder cancer.

Martin DT, Hoimes CJ, Kaimakliotis HZ, Cheng CJ, Zhang K, Liu J, Wheeler MA, Kelly WK, Tew GN, Saltzman WM, Weiss RM.

Nanomedicine. 2013 Nov;9(8):1124-34. doi: 10.1016/j.nano.2013.05.017. Epub 2013 Jun 11.

PMID:
23764660
[PubMed - indexed for MEDLINE]
3.

Survivin specified small interfering RNA-CLIO-Cy5.5.

Zhang H.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2008 Apr 17 [updated 2008 May 12].

PMID:
20641619
[PubMed]
Books & Documents
4.

Dry powders based on PLGA nanoparticles for pulmonary delivery of antibiotics: modulation of encapsulation efficiency, release rate and lung deposition pattern by hydrophilic polymers.

Ungaro F, d'Angelo I, Coletta C, d'Emmanuele di Villa Bianca R, Sorrentino R, Perfetto B, Tufano MA, Miro A, La Rotonda MI, Quaglia F.

J Control Release. 2012 Jan 10;157(1):149-59. doi: 10.1016/j.jconrel.2011.08.010. Epub 2011 Aug 16.

PMID:
21864595
[PubMed - indexed for MEDLINE]
5.

Chitosan film containing poly(D,L-lactic-co-glycolic acid) nanoparticles: a platform for localized dual-drug release.

Tada DB, Singh S, Nagesha D, Jost E, Levy CO, Gultepe E, Cormack R, Makrigiorgos GM, Sridhar S.

Pharm Res. 2010 Aug;27(8):1738-45. doi: 10.1007/s11095-010-0176-9. Epub 2010 Jun 3.

PMID:
20521086
[PubMed - indexed for MEDLINE]
6.

Tumor-homing glycol chitosan/polyethylenimine nanoparticles for the systemic delivery of siRNA in tumor-bearing mice.

Huh MS, Lee SY, Park S, Lee S, Chung H, Lee S, Choi Y, Oh YK, Park JH, Jeong SY, Choi K, Kim K, Kwon IC.

J Control Release. 2010 Jun 1;144(2):134-43. doi: 10.1016/j.jconrel.2010.02.023. Epub 2010 Feb 22.

PMID:
20184928
[PubMed - indexed for MEDLINE]
7.

Biodegradable nanoparticles meet the bronchial airway barrier: how surface properties affect their interaction with mucus and epithelial cells.

Mura S, Hillaireau H, Nicolas J, Kerdine-Römer S, Le Droumaguet B, Deloménie C, Nicolas V, Pallardy M, Tsapis N, Fattal E.

Biomacromolecules. 2011 Nov 14;12(11):4136-43. doi: 10.1021/bm201226x. Epub 2011 Oct 28.

PMID:
21981120
[PubMed - indexed for MEDLINE]
8.
9.

Development of a mucoadhesive nanoparticulate drug delivery system for a targeted drug release in the bladder.

Barthelmes J, Perera G, Hombach J, Dünnhaupt S, Bernkop-Schnürch A.

Int J Pharm. 2011 Sep 15;416(1):339-45. doi: 10.1016/j.ijpharm.2011.06.033. Epub 2011 Jun 24.

PMID:
21726619
[PubMed - indexed for MEDLINE]
10.

Accelerating thrombolysis with chitosan-coated plasminogen activators encapsulated in poly-(lactide-co-glycolide) (PLGA) nanoparticles.

Chung TW, Wang SS, Tsai WJ.

Biomaterials. 2008 Jan;29(2):228-37. Epub 2007 Oct 22.

PMID:
17953984
[PubMed - indexed for MEDLINE]
11.

Development and characterization of surface modified PLGA nanoparticles for nasal vaccine delivery: effect of mucoadhesive coating on antigen uptake and immune adjuvant activity.

Pawar D, Mangal S, Goswami R, Jaganathan KS.

Eur J Pharm Biopharm. 2013 Nov;85(3 Pt A):550-9. doi: 10.1016/j.ejpb.2013.06.017. Epub 2013 Jul 4.

PMID:
23831265
[PubMed - in process]
12.

Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for improving siRNA delivery and gene-silencing effects.

Tahara K, Yamamoto H, Hirashima N, Kawashima Y.

Eur J Pharm Biopharm. 2010 Mar;74(3):421-6. doi: 10.1016/j.ejpb.2009.12.007. Epub 2009 Dec 23.

PMID:
20034563
[PubMed - indexed for MEDLINE]
13.

Enhanced cellular uptake and long-term retention of chitosan-modified iron-oxide nanoparticles for MRI-based cell tracking.

Bakhru SH, Altiok E, Highley C, Delubac D, Suhan J, Hitchens TK, Ho C, Zappe S.

Int J Nanomedicine. 2012;7:4613-23. doi: 10.2147/IJN.S28294. Epub 2012 Aug 22.

PMID:
22942643
[PubMed - indexed for MEDLINE]
Free PMC Article
14.
15.

[Enhancement of gastrointestinal absorption of chitosan-coated insulin-loaded poly (lactic-co-glycolic acid) nanoparticles].

Pan Y, Li YJ, Gao P, Ding PT, Xu H, Zheng JM.

Yao Xue Xue Bao. 2003 Jun;38(6):467-70. Chinese.

PMID:
14513811
[PubMed - indexed for MEDLINE]
16.

Comparative studies on chitosan and polylactic-co-glycolic acid incorporated nanoparticles of low molecular weight heparin.

Yang T, Nyiawung D, Silber A, Hao J, Lai L, Bai S.

AAPS PharmSciTech. 2012 Dec;13(4):1309-18. doi: 10.1208/s12249-012-9854-8. Epub 2012 Sep 28.

PMID:
23054983
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Effect of mitomycin C on concentrations of vascular endothelial growth factor and its receptors in bladder cancer cells and in bladders of rats intravesically instilled with mitomycin C.

Verma A, Degrado J, Hittelman AB, Wheeler MA, Kaimakliotis HZ, Weiss RM.

BJU Int. 2011 Apr;107(7):1154-61. doi: 10.1111/j.1464-410X.2010.09543.x. Epub 2010 Aug 24.

PMID:
20735383
[PubMed - indexed for MEDLINE]
18.

Lung-specific delivery of paclitaxel by chitosan-modified PLGA nanoparticles via transient formation of microaggregates.

Yang R, Yang SG, Shim WS, Cui F, Cheng G, Kim IW, Kim DD, Chung SJ, Shim CK.

J Pharm Sci. 2009 Mar;98(3):970-84. doi: 10.1002/jps.21487.

PMID:
18661542
[PubMed - indexed for MEDLINE]
19.

Low-molecular-weight protamine-modified PLGA nanoparticles for overcoming drug-resistant breast cancer.

Wang H, Zhao Y, Wang H, Gong J, He H, Shin MC, Yang VC, Huang Y.

J Control Release. 2014 Jul 6;192C:47-56. doi: 10.1016/j.jconrel.2014.06.051. [Epub ahead of print]

PMID:
25003794
[PubMed - as supplied by publisher]
20.

Co-delivery of SOX9 genes and anti-Cbfa-1 siRNA coated onto PLGA nanoparticles for chondrogenesis of human MSCs.

Jeon SY, Park JS, Yang HN, Woo DG, Park KH.

Biomaterials. 2012 Jun;33(17):4413-23. doi: 10.1016/j.biomaterials.2012.02.051. Epub 2012 Mar 15.

PMID:
22425025
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk